TY - JOUR
T1 - Palliative care for advanced gastric cancer
AU - Harada, Kazuto
AU - Zhao, Meina
AU - Shanbhag, Namita
AU - Baba, Hideo
AU - Ajani, Jaffer a.
N1 - Publisher Copyright:
© 2020 Informa UK Limited, trading as Taylor & Francis Group.
PY - 2020/7/2
Y1 - 2020/7/2
N2 - Introduction: Proactive palliative care can effectively relieve symptoms early and effectively as well as improve the quality of life of patients with gastric adenocarcinoma (GAC). Areas covered: The review summarizes palliative care for GAC. GAC caused specific symptoms, such as malignant gastric outlet obstruction (GOO), bleeding, weight loss, and/or ascites, therefore, these symptoms must be addressed specifically. Expert opinion: Palliative care should start early to control general symptoms, thus may improve the patient’s condition to make the patient eligible for anti-cancer treatment. As some stage IV GAC patients can now live longer, palliative interventions become more important. A multimodality interdisciplinary approach is strongly encouraged.
AB - Introduction: Proactive palliative care can effectively relieve symptoms early and effectively as well as improve the quality of life of patients with gastric adenocarcinoma (GAC). Areas covered: The review summarizes palliative care for GAC. GAC caused specific symptoms, such as malignant gastric outlet obstruction (GOO), bleeding, weight loss, and/or ascites, therefore, these symptoms must be addressed specifically. Expert opinion: Palliative care should start early to control general symptoms, thus may improve the patient’s condition to make the patient eligible for anti-cancer treatment. As some stage IV GAC patients can now live longer, palliative interventions become more important. A multimodality interdisciplinary approach is strongly encouraged.
KW - Gastric adenocarcinoma
KW - malignant gastric outlet obstruction
KW - palliative care
KW - palliative gastrectomy
KW - palliative radiotherapy
UR - http://www.scopus.com/inward/record.url?scp=85087318404&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85087318404&partnerID=8YFLogxK
U2 - 10.1080/14737140.2020.1781620
DO - 10.1080/14737140.2020.1781620
M3 - Review article
C2 - 32543938
AN - SCOPUS:85087318404
SN - 1473-7140
VL - 20
SP - 575
EP - 580
JO - Expert review of anticancer therapy
JF - Expert review of anticancer therapy
IS - 7
ER -